U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
IDEC-151
Preferred Name English
CLENOLIXIMAB
INN  
INN  
Official Name English
CE9.GAMMA.4PE
Code English
IDEC151
Code English
IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULPHIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER
Common Name English
clenoliximab [INN]
Common Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .LAMBDA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER
Common Name English
Clenoliximab [WHO-DD]
Common Name English
Code System Code Type Description
DRUG BANK
DB06241
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
INN
7615
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
NCI_THESAURUS
C188527
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
SMS_ID
300000021840
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
CAS
182912-58-9
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108187
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
WIKIPEDIA
CLENOLIXIMAB
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
FDA UNII
78EVW7GX37
Created by admin on Wed Apr 02 11:07:04 GMT 2025 , Edited by admin on Wed Apr 02 11:07:04 GMT 2025
PRIMARY
ACTIVE MOIETY
CLENOLIXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966